Max Robotics — Global Service Robot Directory + US Certification

About

Geir Klinkenberg is a microbiologist and biomedical researcher whose work centers on combating antimicrobial resistance through innovative, nature-derived therapeutic strategies. His most significant contributions lie in the development and characterization of alginate oligosaccharides — particularly the compound OligoG, derived from seaweed — as adjunctive agents capable of potentiating conventional antimicrobial treatments. His landmark 2012 paper, which has garnered over 170 citations, demonstrated that low-molecular-weight alginate oligosaccharides could overcome drug resistance by enhancing the efficacy of selected antibiotics against multi-drug resistant pathogens, a finding with profound implications for global healthcare systems struggling with the antibiotic resistance crisis. Building on this foundation, Klinkenberg expanded the scope of this research into antifungal applications, showing in a widely cited 2014 study (89 citations) that OligoG also inhibits fungal cell growth and amplifies the activity of antifungals against Candida and Aspergillus species. More recently, his work has embraced high-throughput screening technologies to accelerate the identification of bioactive compounds against clinically challenging biofilm-forming pathogens. Klinkenberg's research represents a compelling intersection of marine biochemistry and infectious disease, offering promising new avenues in the fight against treatment-resistant microbial infections.